Hanna Nohynek

Summary

Publications

  1. ncbi request reprint Finland introduces rotavirus vaccine into the national vaccination programme in September 2009
    H Nohynek
    Department of Vaccines and Immune Protection, National Institute of Health and Welfare, Helsinki, Finland
    Euro Surveill 14:. 2009
  2. pmc The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
    Diozele Hazel M Sanvictores
    Research Institute for Tropical Medicine, Muntinlupa City, Philippines
    BMC Res Notes 5:274. 2012
  3. pmc Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial
    Antti Tanskanen
    Research Institute for Tropical Medicine, Muntinlupa City, Philippines
    BMC Res Notes 5:51. 2012
  4. pmc AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland
    Hanna Nohynek
    Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 7:e33536. 2012
  5. doi request reprint Childhood bacterial respiratory diseases: past, present, and future
    Hanna Nohynek
    National Institute for Health and Welfare, Helsinki, Finland
    Pediatr Infect Dis J 28:S127-32. 2009
  6. doi request reprint Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease
    Arto A Palmu
    Department of Health Protection, National Institute for Health and Welfare, Tampere, Finland
    Pediatrics 136:e22-7. 2015
  7. pmc No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland
    Krister Melen
    Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 8:e68402. 2013
  8. pmc Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16
    Hanna Nohynek
    Vaccine Programme Unit, Department of Health Protection, National Institute for Health and Welfare, Finland
    Euro Surveill 21:. 2016
  9. pmc Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk
    Outi Vaarala
    Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 9:e114361. 2014
  10. pmc Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study
    Jukka Jokinen
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 10:e0120290. 2015

Collaborators

  • Markku Partinen
  • Arto A Palmu
  • Christer Hublin
  • Terhi M Kilpi
  • Maarit Sillanpää
  • Krister Melen
  • Jukka Jokinen
  • Diozele Hazel M Sanvictores
  • Antti Tanskanen
  • Outi Vaarala
  • Marilla G Lucero
  • Veronica L Tallo
  • Leilani T Nillos
  • Anni Virolainen-Julkunen
  • J Pekka Nuorti
  • Hanna Rinta-Kokko
  • Maija Toropainen
  • Mikko J Virtanen
  • Lotta Siira
  • Merja Roivainen
  • Juha Rouvinen
  • Matti Jauhiainen
  • Päivi Olsen
  • Ilkka Julkunen
  • Tobias L Freitag
  • Arja Vuorela
  • Turkka Kirjavainen
  • Marc Baumann
  • Seppo Meri
  • Rabah Soliymani
  • Outi Saarenpää-Heikkilä
  • Paivi Saavalainen
  • Gail Williams
  • Antti Lehtinen
  • Eric Af Simões

Detail Information

Publications10

  1. ncbi request reprint Finland introduces rotavirus vaccine into the national vaccination programme in September 2009
    H Nohynek
    Department of Vaccines and Immune Protection, National Institute of Health and Welfare, Helsinki, Finland
    Euro Surveill 14:. 2009
    ..The impact of the programme will be evaluated in 2011 by repeating the economic analysis and carefully monitoring adverse events...
  2. pmc The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
    Diozele Hazel M Sanvictores
    Research Institute for Tropical Medicine, Muntinlupa City, Philippines
    BMC Res Notes 5:274. 2012
    ..abstract:..
  3. pmc Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial
    Antti Tanskanen
    Research Institute for Tropical Medicine, Muntinlupa City, Philippines
    BMC Res Notes 5:51. 2012
    ..The information on locations can be used to investigate more accurate crowdedness, herd immunity and/or transmission patterns...
  4. pmc AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland
    Hanna Nohynek
    Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 7:e33536. 2012
    ..A sudden increase in childhood narcolepsy was observed in Finland soon after pandemic influenza epidemic and vaccination with ASO3-adjuvanted Pandemrix. No increase was observed in other age groups...
  5. doi request reprint Childhood bacterial respiratory diseases: past, present, and future
    Hanna Nohynek
    National Institute for Health and Welfare, Helsinki, Finland
    Pediatr Infect Dis J 28:S127-32. 2009
    ..The role of vaccines in this regard is critical, as they represent a rapid and feasible intervention with an early and sustained impact...
  6. doi request reprint Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease
    Arto A Palmu
    Department of Health Protection, National Institute for Health and Welfare, Tampere, Finland
    Pediatrics 136:e22-7. 2015
    ..We evaluated the impact of PCV10 on clinically suspected IPD among vaccine-eligible children in a population-based nationwide study...
  7. pmc No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland
    Krister Melen
    Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 8:e68402. 2013
    ..The analysis was based on the presence or absence of antibody response against non-structural protein 1 (NS1) from H1N1pdm09 virus, which was not a component of Pandemrix vaccine...
  8. pmc Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16
    Hanna Nohynek
    Vaccine Programme Unit, Department of Health Protection, National Institute for Health and Welfare, Finland
    Euro Surveill 21:. 2016
    ..Based on these data, Finland will continue using LAIV for young children in its National Immunisation Programme this coming influenza season. ..
  9. pmc Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk
    Outi Vaarala
    Department of Vaccinations and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 9:e114361. 2014
    ..Hence, antigenic differences and antibody response to these vaccines were investigated...
  10. pmc Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study
    Jukka Jokinen
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 10:e0120290. 2015
    ..We evaluated the direct and indirect effects of PCV10 on invasive pneumococcal disease (IPD) among children ≤5 years of age during the first three years after NVP introduction...